← Back to headlines
NeuroScientific Reports 80% Clinical Response in Crohn's Stem Cell Program
NeuroScientific has announced an 80% clinical response rate in its stem cell program for Crohn's disease, marking a significant development in treatment research.
26 May, 02:02 — 26 May, 02:02
Sources
Showing 1 of 1 sources


